| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.034 | 0.6 |